Startups

EpiThany

Sectors

Biotechnology

Launched

01/01/2015

Website

View Website

EpiThany is a clinical-stage biotechnology company developing therapeutic vaccines for a variety of solid tumors.

Team Members

William Watt
Co-founder and CEO
Nora Disis
Professor, Medicine/Oncology/Tumor Vaccine Group Center for Translational Medicine in Women’s Health, UW Medicine